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Abstract
Background: A three-arm parallel group, randomised controlled trial set in general dental practices in England,
Scotland, and Wales was undertaken to evaluate three strategies to manage dental caries in primary teeth. Children,
with at least one primary molar with caries into dentine, were randomised to receive Conventional with best
practice prevention (C + P), Biological with best practice prevention (B + P), or best practice Prevention Alone (PA).
Methods: Data on costs were collected via case report forms completed by clinical staff at every visit. The co-
primary outcomes were incidence of, and number of episodes of, dental pain and/or infection avoided. The three
strategies were ranked in order of mean cost and a more costly strategy was compared with a less costly strategy
in terms of incremental cost-effectiveness. Costs and outcomes were discounted at 3.5%.
Results: A total of 1144 children were randomised with data on 1058 children (C + P n = 352, B + P n = 352, PA n =
354) used in the analysis. On average, it costs £230 to manage dental caries in primary teeth over a period of up to
36 months. Managing children in PA was, on average, £19 (97.5% CI: -£18 to £55) less costly than managing those
in B + P. In terms of effectiveness, on average, there were fewer incidences of, (− 0.06; 97.5% CI: − 0.14 to 0.02) and
fewer episodes of dental pain and/or infection (− 0.14; 97.5% CI: − 0.29 to 0.71) in B + P compared to PA. C + P was
unlikely to be considered cost-effective, as it was more costly and less effective than B + P.
Conclusions: The mean cost of a child avoiding any dental pain and/or infection (incidence) was £330 and the
mean cost per episode of dental pain and/or infection avoided was £130. At these thresholds B + P has the highest
probability of being considered cost-effective. Over the willingness to pay thresholds considered, the probability of
B + P being considered cost-effective never exceeded 75%.
Trial registration: The trial was prospectively registered with the ISRCTN (reference number ISRCTN77044005) on
the 26th January 2009 and East of Scotland Research Ethics Committee provided ethical approved (REC reference:
12/ES/0047).
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Background
Dental caries has a large health and economic impact
for the United Kingdom (UK) as it is the most com-
mon disease in children [1–4]. Treating oral disease
is expensive, costing NHS England £3.4 billion annu-
ally [5].
In the UK there is uncertainty surrounding the
best strategy to manage caries in primary teeth, es-
pecially in primary care. There is debate about the
clinical- and cost-effectiveness of conventional resto-
rations (removing a carious lesion with a drill and
placement of a restoration) compared to minimally-
invasive biologically-orientated strategies (sealing-in a
carious lesion with an adhesive restoration or pre-
formed metal crown rather than removing it), or
prevention-focused strategies [6–9].
Cost-effectiveness analysis allows treatment com-
parisons in terms of both costs and effects [10]. Re-
cent cost-effectiveness analyses of managing dental
caries found the Hall Technique (HT), a method for
managing carious lesions by sealing-in, to be cost-
effective compared to conventional restorations [11]
and compared to both conventional restorations and
a Non-Restorative Cavity Control approach [12].
However, these studies followed outcomes on single
teeth and have focused on one type of biological ap-
proach (i.e. HT).
A large trial, FiCTION (Filling Children’s Teeth:
Indicated or Not?), was undertaken to measure the
costs and effects, in terms of dental pain and/or in-
fection, of three strategies to manage dental caries in
the primary teeth of young children with dentine
caries in the UK [13]. The strategies evaluated were
Conventional restorations with best practice preven-
tion (C + P), Biological management of carious le-
sions with best practice prevention (B + P), and best
practice Prevention Alone (PA). The C + P strategy
involved the complete mechanical removal of carious
tooth tissue using local anesthesia and a drill
followed by placement of a restoration alongside best
practice preventive therapy and has been considered
standard practice in the management of dental caries
[14, 15]. The B + P strategy involved sealing-in cari-
ous lesions using a variety of techniques including
adhesive restorative materials or preformed metal
crowns placed using the HT along with preventive
therapy; Schwendicke et al.’s (2018, 2019) analyses
focused on the HT component of B + P [11, 12]. PA
involved avoiding restorative intervention and using
four components of preventive management; tooth-
brushing (with toothpaste of at least 1000ppmF
concentration), dietary advice, fluoride varnish appli-
cation, and fissure sealants to prevent further carious
lesions.
The trial methodology and clinical outcomes are
presented elsewhere [13, 16, 17]. In brief, this multi-
center, three-arm, parallel group, patient-randomised
controlled trial set in general dental practices in Eng-
land, Scotland, and Wales was undertaken to evaluate
three strategies to manage caries in the primary teeth
of children aged 3 to 7 years with at least one pri-
mary molar tooth with caries lesions extending into
dentine. The original planned follow-up was 3 years
but due to an extension in the recruitment period
this was revised to an average target follow-up of
35.5 months (a minimum of 23 months and a max-
imum of 36 months).
Methods
Reporting for this study follows the Consolidated
Health Economic Evaluation Reporting Standards
(CHEERS) [18]. The trial was registered with the
ISRCTN (reference number ISRCTN77044005) and
East of Scotland Research Ethics Committee pro-
vided ethical approved (REC reference: 12/ES/0047).
Data analyses
The economic evaluation was undertaken from the
perspective of the healthcare provider in the UK, the
National Health Service (NHS).
Estimation of costs
Time/materials-based costing was used to estimate
the costs at every visit to manage dental caries in
primary teeth. These costs depended on the quantity
of dental care resources used for each child during
their time in the trial (up to 36 months post-
randomisation). Resource use data, to inform the
cost analysis, were collected via case report forms
(CRFs) completed by the clinician at every visit.
Costs were categorised as staffing, preventive treat-
ments, operative treatments (restoration materials),
other associated items (e.g. radiographs), referrals,
and prescriptions. Capital costs were excluded as all
three strategies were provided as part of current
care; therefore, these costs would have been incurred
regardless of which strategy was implemented. Unit
costs, based on the materials required for each treat-
ment, were multiplied by the number of resources
used. Unit costs are detailed in Additional file 1 and
briefly described below. All costs are in 2018 pounds
Sterling.
The length of time for each visit, based on the start
and end time recorded in the CRF, was used to esti-
mate dental personnel costs. Time spent providing
prevention was subtracted from total visit time to
take into account that the same personnel may not
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provide preventive and operative treatments. We as-
sumed a dental nurse would be present for the full
duration of each visit.
Preventive care was integral to all three arms and was
expected to be provided regardless of randomised alloca-
tion. Preventive treatment costs were the resources used
for fluoride applications and fissure sealants placed on
first permanent molars.
Operative treatments were included in two arms;
C + P (e.g. local anesthetic, carious tissue removal,
and restoration) and B + P (e.g. partial/no carious tis-
sue removal and restoration), but some treatments
were included in all three arms (e.g. extractions
under local anesthetic and pulp therapy). Informa-
tion on the number of surfaces treated was also col-
lected since treatment of more than one tooth
surface could incur additional costs (e.g. additional
restorative material). The cost of resources used at
every visit were also included, regardless of treat-
ment. Other treatment costs included radiographs
and inhalation sedation.
A patient referral was reported if a child was referred
to a dental hospital/clinic for a consultation and/or op-
erative treatment. The costs associated with referrals
were categorised A-F (see Additional file 2) depending
on treatment provided, where it took place, who pro-
vided it, and the number of visits required.
Estimation of effects
The original primary outcome, incidence of dental
pain and/or infection was modified during the trial to
include a co-primary outcome, number of episodes of
dental pain and/or infection. Number of episodes was
included as it was considered more clinically relevant
and statistically more sensitive to analyse the fre-
quency of dental pain and/or infection experienced by
a child.
Incidence is defined as the proportion of children
with at least one episode of dental pain and/or infec-
tion during their time in the study. Episodes were
defined on a tooth-by-tooth basis based on the fre-
quency of dental pain and/or infection reported dur-
ing the child’s follow-up. However, if multiple teeth
had dental pain and/or infection at the same visit,
this was counted as one episode or if the same tooth
had dental pain and/or infection at consecutive
visits, this was counted as one episode regardless of
the time between visits [13]. Data on dental pain
due to dental caries and clinically diagnosed infec-
tion were collected on the CRF at every visit. It was
assumed that those who did not have regular ap-
pointments did not need further treatment and/or
did not experience dental pain and/or infection.
Cost-effectiveness analysis
The economic analysis was conducted on the basis
of intention-to-treat (ITT). Children were included
in the ITT analysis if they had at least one CRF and
therefore at least one clinical assessment of the pri-
mary outcome. The economic analysis compared the
three strategies in terms of mean costs and effects
over the follow-up period. Both costs and effects
were discounted at the recommended rate of 3.5%
[19]. Effects were discounted, based on when the in-
cidence or episode of dental pain and/or infection
began. To enable the estimation of budget impact
[20] the average total costs by cost category pre-
sented in Table 1 were not discounted.
For the incremental analysis, the strategies were
ranked in terms of increasing mean cost and a more
costly strategy was compared with a less costly strat-
egy in terms of incremental cost-effectiveness. A
treatment was considered to be dominated if it was
Table 1 Average total cost (£) per child by strategy a
Total cost per child (£)
C + P B + P PA
Resource Mean [SD] Mean [SD] Mean [SD]
Staff costs 18.78 [6.07] 18.28 [6.27] 17.36 [5.95]
Prevention costs 0.66 [0.76] 0.78 [0.88] 0.81 [0.88]
Operative treatment costs 8.18 [6.72] 7.84 [5.96] 4.09 [4.05]
Other treatments costs 0.66 [2.56] 0.47 [1.84] 0.52 [1.90]
Referral costs 5.22 [23.35] 4.96 [23.65] 10.23 [43.81]
Prescription costs 0.07 [0.29] 0.04 [0.14] 0.08 [0.32]
Total practice level treatment cost (exc. referrals) per child per visit 28.36 [11.08] 27.40 [10.81] 22.86 [8.11]
Total treatment cost per child 250.48 (221.70) 231.27 (214.47) 211.32 (257.28)
acosts are not discounted in this table but presented in the common price year to allow for budget impact
Homer et al. BMC Oral Health           (2020) 20:45 Page 3 of 8
more costly and less effective than its comparator
[10]. If a treatment was not dominated, an incre-
mental cost-effectiveness ratio (ICER) was estimated.
The ICER is the difference in mean costs divided by
the difference in mean effects and gives an estimate
of the mean cost per additional unit of effect [10].
STATA software was used for all analyses [21]. Re-
gressions on costs and effects were run simultan-
eously using seemingly unrelated regression (SUR)
[22]. SUR permits the simultaneous estimation of
costs and effects, calculated at an individual level,
while accounting for unobserved individual charac-
teristics that could affect both costs and effects and
lead to potential correlation between these two
dependent variables [23]. In addition, the SUR con-
trolled for additional covariates (age, time in study,
and practice variation) that may affect costs, effects,
or both.
A stochastic sensitivity analysis, using the bootstrap-
ping technique [24], explored the impact of the statis-
tical imprecision surrounding estimates of costs,
effects, and cost-effectiveness. The bootstrapped re-
sults from the incremental analysis were used to esti-
mate net benefits (NB). The NB statistic is given by:
NB ¼ λ Δeð Þ – Δc
where λ is the willingness to pay threshold, Δ is the dif-
ference between a strategy and its comparator (i.e. least
costly strategy), e are the mean effects, and c are the
mean costs [10]. A strategy is considered to be cost-
effective if NB > 0 or, when more than two strategies
are compared, a strategy which has the highest NB at
a given threshold value for society’s willingness to pay
for a unit of oral health benefit. As there is no na-
tionally or internationally agreed willingness to pay
threshold to avoid dental pain and/or infection an ar-
bitrary threshold of £1000, used by O’Neill et al.
(2017), was adopted for this analysis [25]. A cost-
effectiveness frontier [26] was generated to illustrate
uncertainty by showing which strategy was likely to
have the highest NB over a range of different willing-
ness to pay values.
Results
A total of 1144 children were randomised and data
on 1058 children were used in the economic analysis
(n = 86 children did not have any clinical assessment
of the primary outcome and were not included in
the ITT analysis). The children included in the eco-
nomic analysis were evenly distributed across the
three arms in terms of numbers randomised and
baseline characteristics; 352 randomised to B + P, 352
to C + P, and 354 to PA. On average, children were
6 years old [sd: 1.3] when recruited and there was an
even split between females (51%) and males (49%).
The CONSORT (Consolidated Standards of Report-
ing Trial) flow diagram is provided in Additional file
6 but additional baseline characteristics, and clinical
findings are presented elsewhere [13]. The median
follow-up was 33.8 months (IQR 23.8, 36.7).
The percentage of missing data for the economic
analysis was low (< 5%). There were 7713 visits re-
corded across the three arms. On average, children
had seven visits during their time in the trial, each
lasting 21 min. All three strategies were similar in
terms of average number of visits (mean visits [sd]:
C + P 7.7 [4.2], B + P 7.4 [4.1], and PA 6.8 [3.7]) and
duration of visits (mean minutes [sd]: C + P 21.8 [6.9],
B + P 21.2 [7.2], and PA 20.1 [6.7]).
The number of visits at which preventive treatment
was provided was similar across the three arms with
slightly more prevention provided in the PA arm
(C + P 79%, B + P 79%, and PA 85% of visits). The
three strategies differed in the frequency of operative
treatments provided, with less than 20% of all PA
visits involving operative treatment compared to over
40% of B + P and C + P visits. The type of operative
treatment provided also differed, as would be ex-
pected given the nature of the different strategies.
A total of 96 children (C + P n = 31, B + P n = 31,
and PA n = 34 children) were referred on 107 occa-
sions for additional consultations and/or further
treatment (C + P n = 32, B + P n = 36, and PA n = 39
referrals) resulting in 52 general anesthetics (GA) be-
ing undertaken (C + P n = 15, B + P n = 12, PA n = 25
referrals with GA). Four children did not attend
their referral appointment (n = 1 C + P, n = 3 PA).
Table 1 summarizes the average cost per child per
visit for the three strategies.
On average, it cost £230 to manage dental caries in
a young child with at least one primary tooth with a
dentinal carious lesion over a period of up to 36
months. On average, C + P was the most costly and
PA was the least costly strategy. Staff time, operative
treatments, and patient referrals were the main cost
drivers. As expected, C + P and B + P incurred more
operative treatment costs compared to PA.
As PA was, on average, the least costly strategy we
compared this to B + P, the next costly strategy, and
lastly C + P was included in the comparison. In
terms of effectiveness, there was no evidence of a
difference in incidence, or in episodes, of dental pain
and/or infection between the three strategies. Table 2
summaries the results of the incremental analysis.
B + P was, on average, more costly but more effect-
ive, in terms of both incidence of, and episodes of,
dental pain and/or infection avoided, compared to
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PA. At a willingness to pay threshold of £330 we
would consider B + P cost-effective to avoid an inci-
dence and £130 to avoid an episode of dental pain
and/or infection compared to PA. As C + P was, on
average, more costly and less effective than B + P, in
terms of both incidence of, and episodes of, dental
pain and/or infection, it was dominated by B + P.
Figure 1 illustrates uncertainty surrounding the
point estimates in Table 2. The figure presents the
strategy with the highest probability of being consid-
ered cost-effective at each willingness to pay thresh-
old to avoid an incidence of dental pain and/or
infection.
Figure 1 illustrates that PA would have the highest
probability (87%) of being considered cost-effective if
a decision were to be based on cost alone. However,
as the willingness to pay threshold increases, the
probability of B + P being considered cost-effective in-
creases, but it never exceeds 65%. C + P would not be
considered cost-effective compared to PA and B + P
in this analysis.
Figure 2 illustrates the strategy with the highest
probability of being considered cost-effective at the
different willingness to pay thresholds to avoid an
episode of dental pain and/or infection.
In terms of episodes of dental pain and/or infection,
the conclusions are similar except that B + P would
be considered cost-effective at a lower willingness to
pay threshold. The probability of B + P being consid-
ered cost-effective never exceeds 75%.
Fig. 1 Probability of being cost-effective to avoid an incidence of dental pain and/or infection
Table 2 Cost-effectiveness analysis for the comparison of PA vs B + P vs C + P a
Investigation strategy Cost [£] [97.5% CI]b Incremental cost [£]
[97.5% CI]b c
Incidence [97.5% CI]b Incremental incidence
[97.5% CI]b c
ICERc [£]
Incremental cost per incidence of dental pain and/or infection avoided
PA (n = 354) 206 [176 to 237] 0.44 [0.39 to 0.50]
B + P (n = 352) 226 [201 to 252] 19 [−18 to 55] 0.39 [0.33 to 0.45] −0.058 [−0.14 to 0.02] 328
C + P (n = 352) 245 [219 to 271] 0.41 [0.35 to 0.47] Dominated by B + P
Incremental cost per episode of dental pain and/or infection avoided
Investigation strategy Cost [£]
[97.5% CI]b
Incremental cost [£]
[97.5% CI]b c
Episodes
[97.5% CI]b
Incremental episodes
[97.5% CI]b c
ICER c [£]
PA (n = 354) 206 [176 to 237] 0.70 [0.58 to 0.82]
B + P (n = 352) 226 [201 to 252] 19 [−18 to 55] 0.56 [0.46 to 0.67] −0.143 [−0.29 to 0.01] 133
C + P (n = 352) 245 [219 to 271] 0.60 [0.49 to 0.71] Dominated by B + P
a costs and effects are discounted at 3.5%; b 97.5% CI was used as it adjusts for multiple comparisons and should be interpreted as if it were a 95% CI; c estimated
based on adjusted analysis (n = 1057; n = 1 child missing information on age); d ICER = incremental cost-effectiveness ratio
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Discussion
On average, it costs £230 to manage dental caries in
primary teeth in a child with at least one tooth with
a dentinal caries lesion over a period of up to 36
months. The main cost drivers were staff time, opera-
tive treatments, and patient referrals. On average, PA
incurred a higher referral cost because that arm had
more referrals and more referrals requiring GA, an
important consideration in view of the morbidity as-
sociated with GA use [27–29].
Although in terms of cost-effectiveness PA was, on
average, the least costly treatment, it was also the
least effective for both incidence of, and episodes of,
dental pain and/or infection. There was an 87% prob-
ability that PA would be considered cost-effective as
the least costly option but B + P and C + P would, on
average, provide more oral health benefits, albeit at a
higher cost. If society was willing to pay £330 to
avoid one additional child experiencing dental pain
and/or infection, B + P would have the highest prob-
ability (47%) of being considered cost-effective com-
pared to PA (46%) and C + P (7%). Similarly, when
society is willing to pay £130 or more to avoid an
episode of dental pain and/or infection, B + P would
have the highest probability (49%) of being considered
cost-effective compared to PA (45%) and C + P (6%).
Vermaire et al. (2014) and Samnaliev et al. (2015)
came to similar conclusions in their analyses, in that
treatments aimed at caries prevention increased the
cost of providing treatment and that the opportunity
cost of these treatments is dependent on the payers’
willingness-to-pay [30, 31]. Our results differ from
other studies in which the HT, which was a compo-
nent of our B + P intervention, was reported to be
more effective and less costly [11, 12] when compared
to conventional and preventive based strategies. How-
ever, both of these studies by Schwendicke et al.
(2018, 2019) were based on treating a single tooth, or
two contralateral teeth per child whereas in our study
the whole child/mouth (up to 20 primary teeth per
child) could be treated, a situation more representa-
tive of real life treatment provision [11, 12]. Our
study also had considerably more data available to in-
form our analysis (n = 1058 children, n = 2721 teeth;
compared with n = 142 children and teeth in Schwen-
dicke et al. 2018; and n = 91 children, n = 182 teeth in
Schwendicke et al. 2019) [11, 12]. The costs estimated
in the two Schwendicke et al. (2018, 2019) studies
were based on current charges to the health system
[11, 12]. In the present analysis we based our costs
on a very detailed costing exercise, however, when we
used current charges to the NHS in a sensitivity ana-
lysis we still reached the same conclusion (see Add-
itional files 3, 4, and 5). Schwendicke et al. (2019)
found a negligible difference in total treatment costs
between HT and conventional treatment and this
difference only became clinically and statistically sig-
nificant when patient costs were considered [11]. Par-
ental time and travel costs to attend appointments
were not considered in our analysis. Inclusion of such
costs are unlikely to change our conclusions as the
average number of visits and length of visits were
similar across the arms. Costs incurred by the parent
and child due to toothache, such as time off work,
Fig. 2 Probability of being cost-effective to avoid an episode of dental pain and/or infection
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childcare, and time off school, were considered in a
sensitivity analysis but did not change our overall
conclusions. In terms of oral health effects, direct
comparisons could not be made with previous studies
[11, 12] which considered the pain associated with
dental caries together with endodontic treatment and
extractions. The main differences in our study are,
firstly, that B + P encompassed a number of
minimally-invasive restorations of which the HT was
only one and secondly, treatment was at the partici-
pant level (including all primary teeth) and not at the
single tooth level.
This economic analysis had a number of strengths
and limitations. The main strength was that the ana-
lysis was pre-planned and the data used were col-
lected as part of the trial. There were few missing
data and all available data were included in the ana-
lysis despite the varying follow-up. A limitation of the
analysis was that SUR model may not have been an
appropriate fit for the co-primary outcomes. However,
a trade-off was made between fitting the most appro-
priate model and applying one that allows for the
correlation of costs and outcomes, which the SUR ap-
proach does. Finally, capital costs were excluded from
the analysis; this omission reduced the total cost of
each arm equally hence the incremental costs, ICER,
and our overall conclusions remain unchanged.
In practical terms, we do not know society’s willing-
ness to pay threshold to avoid dental pain and/or in-
fection in a primary tooth. A judgement is required
as to what value the NHS places on avoiding dental
pain and/or infection. Recent research conducted by
Lord et al. (2015) estimated the willingness to pay to
avoid dental caries with pain in a primary tooth [32].
They estimated this to be £153 (95% CI: £93 to £213
– inflated to 2017) [33]. If we adopted this as the
willingness to pay threshold the PA arm would have
a 68% probability of being considered cost-effective
compared to B + P (29%) and C + P (3%) in terms of
an incidence of dental pain and/or infection avoided.
A willingness to pay threshold to avoid an episode of
dental pain and/or infection also needs to be deter-
mined but based on the Lord et al. (2015) threshold,
B + P would have the highest probability (53%) of be-
ing considered cost-effective compared to PA (40%)
and C + P (7%). Further research is needed to identify
the most appropriate threshold to assess our results.
Conclusions
To conclude, on average, PA is the least costly, des-
pite having more referrals requiring GA, but the least
effective strategy for managing dental caries in pri-
mary teeth. B + P has the potential to provide more
oral health benefits to children with dentinal carious
lesion in at least one primary molar tooth, however
this comes at an additional cost. Over the willingness
to pay values considered, the probability of B + P be-
ing considered cost-effective was approximately no
higher than 65% to avoid an incidence of dental pain
and/or infection and no higher than 75% to avoid an
episode of dental pain and/or infection. It is unlikely
that C + P would be considered cost-effective.
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